Aligned with these potential tumor repressive actions of KLF9 are the findings that miR-600, which targets the 3′-UTR of KLF9 mRNA, is more highly expressed in ovarian cancers than in normal tissue, and elicited effects opposite to those of KLF9 in ovarian cancer cells [158]. This evidence concerns the gene KLF9 and ovarian carcinoma.